Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
OBR Daily’s featured oncology news headlines for Wednesday, October 30, included 2 articles from The American Journal of Managed Care® (AJMC®)’s coverage of the Community Oncology Alliance Payer Exchange Summit 2019: “Moving Into the Future of Cancer Care Through OCM 2.0” and “Providers Move Forward With 2-Sided Risk and Take on Pharma.”
The Wednesday OBR Daily newsletter also included an article from AJMC®’s sister site The Center for Biosimilars® titled “Pfizer Announces Launch Dates for 2 More Anticancer Biosimilars: Ruxience and Trazimera.” The article listed the dates on which the 2 anticancer biosimilars will become commercially available to the public.
An article in the Philly Voice, “Doctors, nurses are burned out on the job, does that put patients’ health at risk?” referenced a 2018 AJMC® newsroom article in its findings. The article, titled “Physician Burnout Associated With Poorer Patient Outcomes,” reported that physician burnout is associated with an increased risk of patient safety incidents, poorer quality of care, and reduced patient satisfaction.
A press release issued by MDVIP, “Three Florida Doctors Join National MDVIP Network to Provide Personalized, Preventive Primary Care,” cited a study in the December 2012 issue of AJMC®, “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization.” The AJMC® study assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found that MDVIP members’ utilizationrates were substantially lower than those of nonmembers.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More